【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Global Markets Direct Report Coverage 7
Bone Marrow Transplantation Overview 8
Therapeutics Development 9
Pipeline Products for Bone Marrow Transplantation – Overview 9
Pipeline Products for Bone Marrow Transplantation – Comparative Analysis 10
Bone Marrow Transplantation – Therapeutics under Development by Companies 11
Bone Marrow Transplantation – Therapeutics under Investigation by Universities/Institutes 12
Bone Marrow Transplantation – Pipeline Products Glance 13
Late Stage Products 13
Clinical Stage Products 14
Early Stage Products 15
Bone Marrow Transplantation – Products under Development by Companies 16
Bone Marrow Transplantation – Products under Investigation by Universities/Institutes 17
Bone Marrow Transplantation – Companies Involved in Therapeutics Development 18
Anchor Therapeutics, Inc. 18
Boryung Pharmaceutical Co., Ltd. 19
Cantex Pharmaceuticals, Inc. 20
Cellerant Therapeutics, Inc. 21
Cleveland BioLabs, Inc. 22
Compugen Ltd. 23
Mesoblast Limited 24
Pluristem Therapeutics Inc. 25
Proteonomix, Inc. 26
Spectrum Pharmaceuticals, Inc. 27
Taiga Biotechnologies, Inc. 28
Wellstat Therapeutics Corporation 29
Bone Marrow Transplantation – Therapeutics Assessment 30
Assessment by Monotherapy Products 30
Assessment by Combination Products 31
Assessment by Target 32
Assessment by Mechanism of Action 34
Assessment by Route of Administration 36
Assessment by Molecule Type 38
Drug Profiles 40
(filgrastim + plerixafor) – Drug Profile 40
Product Description 40
Mechanism of Action 40
R&D Progress 40
ATI-2341 – Drug Profile 42
Product Description 42
Mechanism of Action 42
R&D Progress 42
BR-05001 – Drug Profile 44
Product Description 44
Mechanism of Action 44
R&D Progress 44
CBLB-612 – Drug Profile 45
Product Description 45
Mechanism of Action 45
R&D Progress 45
Cell Therapy for Bone Marrow Transplantation – Drug Profile 46
Product Description 46
Mechanism of Action 46
R&D Progress 46
CGEN-15001 – Drug Profile 47
Product Description 47
Mechanism of Action 47
R&D Progress 47
melphalan – Drug Profile 48
Product Description 48
Mechanism of Action 48
R&D Progress 48
MPC-CBE – Drug Profile 49
Product Description 49
Mechanism of Action 49
R&D Progress 49
PGX-100 – Drug Profile 51
Product Description 51
Mechanism of Action 51
R&D Progress 51
PLX-RAD – Drug Profile 53
Product Description 53
Mechanism of Action 53
R&D Progress 53
PN-951 – Drug Profile 56
Product Description 56
Mechanism of Action 56
R&D Progress 56
Protein for Bone Marrow Transplantation – Drug Profile 57
Product Description 57
Mechanism of Action 57
R&D Progress 57
romyelocel-L – Drug Profile 58
Product Description 58
Mechanism of Action 58
R&D Progress 58
Small Molecules to Inhibit Perforin for Bone Marrow Transplantation – Drug Profile 59
Product Description 59
Mechanism of Action 59
R&D Progress 59
Bone Marrow Transplantation – Recent Pipeline Updates 60
Bone Marrow Transplantation – Dormant Projects 70
Bone Marrow Transplantation – Discontinued Products 71
Bone Marrow Transplantation – Product Development Milestones 72
Featured News & Press Releases 72
Mar 03, 2015: Pluristem and Hadassah Medical Center Announce Significant Data Showing PLX-R18 Cells Improve Bone Marrow Transplantation 72
Dec 04, 2014: Pluristem and Hadassah Medical Center Will Collaborate to Study Potential of PLX-RAD Cells to Improve Bone Marrow and Umbilical Cord Blood Transplant Outcomes 73
Nov 13, 2014: Cell Source’s Megadose Drug Combination Receives Regulatory Approval in Italy to Commence Human Clinical Trials 74
Oct 27, 2014: Case Western Reserve University to Study Pluristem’s PLX-RAD Cells in Umbilical Cord Blood Transplants for the Treatment of Blood Cancers and Genetic Diseases 74
Apr 23, 2014: Spectrum Pharmaceuticals’ Pivotal Trial of Captisol-Enabled Melphalan Meets Primary Endpoint 75
May 07, 2013: Pluristem Develops PLX-RAD Cells For Use In Hematology 76
Sep 05, 2012: Pluristem Therapeutics Announces Successfully Treatment Of Third Critically Ill Patient With PLX Cells Under Compassionate Use 77
May 09, 2012: Pluristem’s PLX Cells Saves Life Of Child After Bone Marrow Transplantation Failure 78
Feb 01, 2012: Ligand Presents Successful Phase II Results For Captisol-Enabled, Propylene Glycol-Free Melphalan At BMT Tandem Meetings 79
Jul 07, 2011: Mesoblast Receives FDA Clearance For Phase III Bone Marrow Transplant Trial 80
Appendix 82
Methodology 82
Coverage 82
Secondary Research 82
Primary Research 82
Expert Panel Validation 82
Contact Us 82
Disclaimer 83
【レポート販売概要】
■ タイトル：骨髄移植(Bone Marrow Transplantation)：治療薬開発パイプライン動向（2015年上半期版）■ 英文：Bone Marrow Transplantation - Pipeline Review, H1 2015
■ 発行日：2015年3月19日
■ 調査会社：Global Markets Direct
■ 商品コード：GMDHC6432IDB
■ 調査対象地域：グローバル
- 医療産業における3Dプリンティングの世界市場Three dimensional printing for medical applications – how to find trends, technologies and sales potentials What's the future of additive manufacturing for medicine? That's fabricating three dimensional solid objects from digital models, via 3D printers. Visiongain’s new report gives data and analysis, letting you explore developments, technology and revenue predictions. That analysis forecasts re …
- 清涼飲料販売機の世界市場2019-2023Technavio Announces the Publication of its Research Report – Global Soft Drink Dispensers Market 2019-2023 Technavio recognizes the following companies as the key players in the global soft drink dispensers market: Cornelius, Inc, Lancer Corporation, Multiplex Beverage, PepsiCo, THE COCA-COLA COMPANY. Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining moment …
- デジタルパッケージング及びラベリングの世界市場About Digital Packaging and Labeling Digital packaging and labeling is a modern technique of packaging and labeling various manufactured and non-manufactured goods. In this technique, the image is transferred to the substrate from a digital storage device, with the help of a device that supports digital images or texts. The process involves a complex set of arithmetic formula, related to each imag …
- 行動リハビリの世界市場の規模および予測：用途別（不安、気分障害、物質乱用、人格、注意欠陥障害）、医療現場別（入院患者、家庭内、外来患者）、動向の分析 2014-2025The global behavioral rehabilitation market is expected to reach USD 313.9 billion by 2025, according to a new report by Grand View Research, Inc. Behavioral rehabilitation market is anticipated to experience growth during the forecast period due to presence of favorable government initiatives, rising number of service providers, and growing awareness among patients. Furthermore, increasing incide …
- スチレンの世界市場予測Styrene 2013 World Market Outlook and Forecast is an absolutely essential resource for anyone looking for detailed information on the mentioned market. Using a wide range of primary and secondary sources, we combined, analyzed and presented all available data about Styrene market in the all-in-one report issued in a logical and easily accessible format. In addition to the analytical part, the repo …
- 通信キャリア向け運用管理ソリューションの世界市場Due to rise in competition in the telecommunication sector, operators need to differentiate themselves from their competitors. This has led to an increase in complexities of their service and network management operations to meet differentiated customer expectations. The telecom companies face high costs in order to facilitate these operations and they look for operations support solutions to effe …
- 人工心臓の世界市場分析：製品別（左、右、両腕補助装置）、セグメント予測The global ventricular assist device market is expected to reach USD 1.97 billion by 2022, according to a new report by Grand View Research, Inc. Key factors attributing to its rapid growth include rising prevalence of cardiovascular disorders coupled with the development of technological advanced products such as miniature device with infection reduction technology. Furthermore, increasing health …
- Brivaracetam (Epilepsy)：市場予測と分析（～2022）Brivaracetam (Epilepsy) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Brivaracetam (Epilepsy) - Forecast and Market Analysis to 2022”. Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure reduction …
- 抗ウイルス薬の世界市場2017-2021About Antiviral DrugsAntiviral drugs are agents used to cure a viral infection by inhibiting the growth of viral pathogens. There are two types of antiviral agents which includes narrow-spectrum antiviral agents and broad-spectrum antiviral agents. Technavio’s analysts forecast the global antiviral drugs market to grow at a CAGR of 9.48% during the period 2017-2021. [Covered in this report] The re …
- スーパーキャパシタの世界市場2018-2022About Supercapacitor A supercapacitor is an energy storage device. It is electrochemical in nature and has a relatively high-energy density than other capacitors or batteries. This device has a higher power capacity, longer life cycle, and faster-charging option than batteries. Supercapacitors are also known as electrical double-layer capacitors or ultracapacitors. Technavio’s analysts forecast th …
- Nonalcoholic Steatohepatitis (NASH)：市場分析及び予測（～2017）OpportunityAnalyzer: Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2017 Summary GlobalData has released its new report, “OpportunityAnalyzer: Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2017”. The NASH market is currently deserted and awaits its first NASH-specific therapy. With novel mechanism of action awaiting approval such as: Genfi …
- 2G/3G/4Gモバイルネットワーク加入者、スペクトラムライセンス、所有権、インフラ契約、端末出荷データシート2013-2020（2G, 3G & 4G Mobile Network Subscriptions, Spectrum Licensing, Ownership, Infrastructure Contracts & Handset Shipments Database: 2013-2020）With mobile network subscriptions estimated to reach 7.4 billion by the end of 2013, global mobile penetration is fast approaching the 100% mark. Mobile broadband in particular is witnessing considerable growth. SNS Research estimates that HSPA subscriptions have already crossed the 1 Billion mark. LTE is estimated to account for nearly 130 Million subscriptions at the end of 2013. Driven by ongoi …
- 船舶用推進機関の世界市場：ディーゼルエンジン、ガスタービンエンジンAbout Marine Propulsion Engines The first kind of mechanical marine propulsion engines was the steam engines that came into inception during the 19th century. With time, steam engines have been increasingly replaced by two-stroke and four-stroke diesel engines and gas turbine engines from the 20th century onward. The use of LNG (liquefied natural gas) as a fuel in the marine propulsion engine is g …
- Ultra Petroleum Corp.：石油・ガスバリューチェーン分析レポート2013Ultra Petroleum Corp. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Ultra Petroleum Corp." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Ultra Petroleum Corp.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report e …
- 自動車用ショックアブソーバーゴムの世界市場ABSTRACTAbout Automotive Shock Absorber Rubber Automotive shock absorber rubber is the rubber that is used for mounting and boot of shock absorbers to protect them from mud, water, pollutants, dust particles, and chipping stones. The raw rubber, which comprises of natural polymer or elastomer, can be divided into two broad categories, namely natural rubber and synthetic rubber. Technavio’s analyst …
